Answers are grounded in this paper and cite their sources.
A novel, simple approach to retrospective assessment of "blindability" was applied to data on outpatients in a controlled, double-blind clinical comparison of a putative antidepressant, etoperidone, and placebo. A "blind" evaluator proved capable of discriminating between the active drug and placebo on the basis of reported side effects alone, raising questions about the true blindness of the study.
No takes yet. Share an insight, caveat, or question.
White et al. (1992) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: